Cystic Fibrosis

Pulmonology focuses on diagnosing and treating lung and airway conditions such as asthma, COPD, and pneumonia, as well as overall respiratory health.

Cystic Fibrosis Overview and Definition

Cystic fibrosis is caused by changes in the CFTR gene. This gene helps make a protein that controls chloride and water movement across cell surfaces.

When the CFTR protein does not work properly, secretions can become thick and difficult to clear.

Cystic fibrosis is not contagious. It is inherited, which means it is passed through genes from parents to children.

Understanding Cystic Fibrosis and Mucus Buildup

Cystic fibrosis is a genetic condition that affects how salt and water move in and out of cells. This can make mucus thicker and stickier than normal.

Thick mucus may collect in the lungs, pancreas, sinuses, intestines, liver, and reproductive system. In the lungs, it can block airways and make infections more likely.

At Liv Hospital, cystic fibrosis care begins with understanding the patient’s symptoms, genetic background, lung health, nutrition, infection history, and daily needs.

The aim is to support clearer breathing, better digestion, infection control, and long-term follow-up.

Symptoms and Risk Factors

Cystic fibrosis symptoms can begin in infancy, childhood, adolescence, or even adulthood in milder cases. The signs may involve both the lungs and digestive system.

Common symptoms may include:

• Long-lasting cough
• Thick mucus
• Repeated lung infections
• Wheezing
• Shortness of breath
• Poor weight gain
• Greasy or bulky stools
• Salty-tasting skin
• Nasal polyps or sinus problems
• Delayed growth in children

Risk is linked to inheriting two non-working CFTR gene copies, one from each parent. Family history and carrier status are important in genetic counseling.

Patients who want to review warning signs and inherited risks can continue to the Cystic Fibrosis Symptoms and Risk Factors section.

Diagnosis and Evaluation

Cystic fibrosis diagnosis requires structured testing. Symptoms may suggest the condition, but confirmation usually needs laboratory and genetic evaluation.

Diagnosis may include:

• Newborn screening
• Sweat chloride test
• CFTR genetic testing
• Medical history
• Physical examination
• Lung function testing
• Sputum culture
• Chest imaging when needed
• Pancreatic function assessment
• Growth and nutrition review

The sweat chloride test helps measure salt levels in sweat. Genetic testing can identify CFTR changes and support treatment planning.

At Liv Hospital, pulmonology specialists evaluate respiratory findings together with nutrition, infection history, and systemic involvement. Patients can learn more in the Cystic Fibrosis Diagnosis and Evaluation section.

Treatment and Management

Cystic fibrosis treatment focuses on clearing mucus, preventing infections, supporting digestion, and protecting lung function as much as possible.

The care plan changes according to age, symptoms, lung function, bacteria found in sputum, pancreatic involvement, and CFTR mutation type.

Treatment may include:

• Airway clearance techniques
• Inhaled medications
• Antibiotics for infections
• Pancreatic enzyme replacement
• Nutrition support
• Vitamins when needed
• CFTR modulator therapy for eligible patients
• Pulmonary rehabilitation
• Regular sputum monitoring
• Vaccination planning

CFTR modulators may target the underlying protein problem in selected patients with specific genetic variants. They are not suitable for every mutation type.

For care options in detail, patients can visit the Cystic Fibrosis Treatment and Management section.

Recovery and Prevention

Cystic fibrosis is usually managed as a lifelong condition. Recovery means better daily control, fewer complications, and more stable breathing and nutrition.

Prevention focuses on reducing infection risk, keeping mucus moving, and following the care plan consistently.

Prevention steps may include:

• Daily airway clearance
• Hand hygiene
• Avoiding close contact with respiratory infections
• Regular sputum cultures
• Nutrition follow-up
• Using enzymes correctly when prescribed
• Keeping vaccines up to date
• Monitoring weight and growth
• Attending routine specialist visits
• Recognizing flare-up signs early

Patients should seek medical support if cough worsens, sputum changes, fever appears, weight drops, or breathing becomes harder.

For long-term care guidance, patients can visit the Cystic Fibrosis Recovery and Prevention section.

The Role of the CFTR Protein

The CFTR protein works like a channel on the surface of certain cells. It helps move chloride and water, which keeps mucus and other secretions properly hydrated.

When this protein is missing or not working well, mucus becomes thicker. The lungs then have more difficulty clearing germs, dust, and secretions.

This can create a cycle of mucus blockage, infection, inflammation, and airway damage.

At Liv Hospital, CFTR-related findings are considered together with the patient’s symptoms and genetic results.

Ion Transport Failure and Airway Clearance

Healthy airways depend on a thin, moist surface layer. This allows tiny hair-like structures, called cilia, to move mucus out of the lungs.

In cystic fibrosis, this surface layer can become too dry. Mucus becomes sticky and may stay attached to the airway wall.

This can lead to:

• Mucus plugs
• Chronic cough
• Repeated bacterial growth
• Airway inflammation
• Bronchiectasis over time
• Reduced lung function

Airway clearance is therefore a central part of cystic fibrosis care.

Patients are guided according to age, lung status, sputum pattern, and daily routine.

CFTR Mutation Classes

There are many CFTR gene changes. Different mutations can affect the protein in different ways.

Some mutations prevent the protein from being made. Others cause the protein to fold incorrectly, fail to open properly, or work in reduced amounts.

Mutation type matters because it may influence:

• Disease severity
• Pancreatic involvement
• Age at diagnosis
• Eligibility for CFTR modulators
• Long-term monitoring needs
• Family genetic counseling

Genetic testing helps doctors understand which CFTR changes are present.

This information can support more personalized care planning.

Digestive and Pancreatic Involvement

Cystic fibrosis can affect digestion because thick secretions may block pancreatic ducts. When digestive enzymes do not reach the intestine properly, food is harder to absorb.

Possible digestive signs may include:

• Poor weight gain
• Frequent bulky stools
• Greasy stools
• Bloating
• Malnutrition risk
• Fat-soluble vitamin deficiency
• Delayed growth in children

Pancreatic enzyme replacement may be needed in patients with pancreatic insufficiency.

At Liv Hospital, nutrition and digestive support can be coordinated with respiratory care because both areas affect long-term health.

Liver, Sinus, and Reproductive Effects

Cystic fibrosis can involve organs beyond the lungs and pancreas. The same thick secretion problem may affect bile ducts, sinuses, and reproductive anatomy.

Possible related concerns may include:

• Chronic sinusitis
• Nasal polyps
• Liver or bile duct involvement
• Gallbladder problems
• Male infertility due to vas deferens absence
• Fertility challenges in some women
• Need for multisystem follow-up

Not every patient develops all of these problems. The care plan should be adapted to the individual.

Liv Hospital evaluates cystic fibrosis as a whole-body condition, not only a lung disorder.

Microbiome, Infection, and Inflammation

Thick mucus can create an environment where bacteria may settle and grow. Over time, repeated infection and inflammation may affect lung structure.

Sputum cultures help doctors identify which organisms are present. This can guide antibiotic decisions and follow-up planning.

Common care priorities may include:

• Monitoring bacteria in sputum
• Treating infections early
• Reducing inflammation-related damage
• Supporting airway clearance
• Reviewing lung function regularly
• Preventing cross-infection when possible

Infection control is especially important in cystic fibrosis care because some bacteria can be difficult to treat.

At Liv Hospital, respiratory monitoring is planned according to each patient’s risk profile.

Why Choose Liv Hospital for Cystic Fibrosis Care?

Cystic fibrosis care should be detailed, coordinated, and easy for patients and families to follow. Liv Hospital supports patients with pulmonology expertise, diagnostic evaluation, lung function testing, imaging when needed, sputum monitoring, nutrition guidance, and multidisciplinary care planning.

For international patients, Liv Hospital can assist with appointment planning, communication support, diagnostic coordination, treatment review, second opinion evaluation, and follow-up guidance.

If cystic fibrosis symptoms, repeated infections, thick mucus, poor weight gain, or breathing difficulty affect daily life, Liv Hospital can help guide the next step.

Take the Next Step with Liv Hospital

Cystic fibrosis requires careful follow-up, not only short-term symptom treatment.

Contact Liv Hospital to discuss symptoms, genetic evaluation, lung health, digestive support, and personalized care planning with experienced medical teams.